Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DONNA ARGENZIO

Allopathic & Osteopathic Physicians Pediatrics

NPI
1053434134
CMS profile
962841
Location
NEWBURGH, NY

General Payments · PY2018–2024

$1,379.80

  • Reported across 72 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$303.79

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $303.79 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $90.24 5
PFIZER INC. $86.83 4
Seqirus USA Inc $33.36 1
GlaxoSmithKline, LLC. $27.19 1
UCB, Inc. $26.50 1
SANOFI PASTEUR INC. $23.72 1
Cranial Technologies, Inc $15.95 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $265.01 18
PY2019 $305.01 14
PY2020 $60.61 4
PY2021 $49.09 2
PY2022 $127.47 7
PY2023 $268.82 13
PY2024 $303.79 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Cranial Technologies, Inc $15.95 07/02/2024 Food and Beverage Undisputed 01/23/2026 1082217130 CMS
GlaxoSmithKline, LLC. $27.19 01/17/2024 Food and Beverage Undisputed 01/23/2026 1116607096 CMS
Merck Sharp & Dohme LLC $19.24 01/24/2024 Food and Beverage Undisputed 01/23/2026 1141980745 CMS
Merck Sharp & Dohme LLC $19.10 03/19/2024 Food and Beverage Undisputed 01/23/2026 1141971853 CMS
Merck Sharp & Dohme LLC $17.34 05/01/2024 Food and Beverage Undisputed 01/23/2026 1141595132 CMS
Merck Sharp & Dohme LLC $16.09 06/12/2024 Food and Beverage Undisputed 01/23/2026 1141967189 CMS
Merck Sharp & Dohme LLC $18.47 10/02/2024 Food and Beverage Undisputed 01/23/2026 1141837612 CMS
PFIZER INC. $28.34 03/06/2024 Food and Beverage Undisputed 01/23/2026 1131238322 CMS
PFIZER INC. $16.89 04/04/2024 Food and Beverage Undisputed 01/23/2026 1131394869 CMS
PFIZER INC. $22.29 07/09/2024 Food and Beverage Undisputed 01/23/2026 1131658739 CMS
PFIZER INC. $19.31 10/30/2024 Food and Beverage Undisputed 01/23/2026 1132102901 CMS
SANOFI PASTEUR INC. $23.72 11/12/2024 Food and Beverage Undisputed 01/23/2026 1128741708 CMS
Seqirus USA Inc $33.36 10/09/2024 Food and Beverage Undisputed 01/23/2026 1125629018 CMS
UCB, Inc. $26.50 09/04/2024 Food and Beverage Undisputed 01/23/2026 1143305104 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.